BIOCQ (Biocept) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOCQ Biocept Inc BIOCQ
16 GF Score
Price $0.00
View Full Analysis

What is Biocept Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biocept  (OTCPK:BIOCQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biocept Cyclically Adjusted PB Ratio Related Terms


Biocept Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Biocept's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocept Cyclically Adjusted PB Ratio Chart

Biocept Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biocept Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BIOCQ vs IDTA, DIGP, ABMC: Cyclically Adjusted PB Ratio Comparison

For the Diagnostics & Research subindustry, Biocept's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocept Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biocept's Cyclically Adjusted PB Ratio falls into.


BIOCQ
16GF Score
Biocept Inc BIOCQ
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocept Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biocept's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Biocept's adjusted Book Value per Share data for the three months ended in Jun. 2023 was:

Adj_Book=Book Value per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.12/305.1090*305.1090
=0.120

Current CPI (Jun. 2023) = 305.1090.

Biocept Quarterly Data

Book Value per Share CPI Adj_Book
201306 -86,929.664 233.504 -113,587.017
201309 234.149 0.000
201312 -1,813,526.340 233.049 -2,374,278.405
201403 18,508.451 236.293 23,898.698
201406 13,615.653 238.343 17,429.747
201409 6,616.472 238.031 8,481.018
201412 -1,338.403 234.812 -1,739.088
201503 20,490.245 236.119 26,477.150
201506 16,000.066 238.638 20,456.776
201509 9,967.733 237.945 12,781.294
201512 5,068.814 236.525 6,538.593
201603 -661.010 238.132 -846.926
201606 -453.499 241.018 -574.093
201609 -4,881.948 241.428 -6,169.650
201612 338.752 241.432 428.097
201703 3,524.878 243.801 4,411.270
201706 2,302.684 244.955 2,868.158
201709 738.644 246.819 913.086
201712 331.525 246.524 410.310
201803 1,125.386 249.554 1,375.916
201806 332.256 251.989 402.297
201809 681.069 252.439 823.170
201812 197.175 251.233 239.458
201903 222.829 254.202 267.453
201906 170.728 256.143 203.366
201909 100.426 256.759 119.337
201912 61.386 256.974 72.884
202003 62.728 258.115 74.149
202006 59.639 257.797 70.584
202009 47.818 260.280 56.054
202012 53.054 260.474 62.145
202103 59.924 264.877 69.026
202106 61.532 271.696 69.099
202109 70.198 274.310 78.080
202112 66.731 278.802 73.028
202203 65.926 287.504 69.963
202206 57.536 296.311 59.244
202209 31.912 296.808 32.805
202303 4.095 301.836 4.139
202306 0.120 305.109 0.120

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biocept Business Description

Address 9955 Mesa Rim Road, San Diego, CA, USA, 92121
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
16GF Score

Get the complete analysis for BIOCQ

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price